12:00 AM
 | 
Apr 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

Nuron, Vitruvian Biomedical deal

Vitruvian granted Nuron exclusive, worldwide rights to develop and commercialize Vitruvian's AB42 vaccine, a DNA vaccine containing...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >